Correlation Between Revelation Biosciences and Immunocore Holdings
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Immunocore Holdings, you can compare the effects of market volatilities on Revelation Biosciences and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Immunocore Holdings.
Diversification Opportunities for Revelation Biosciences and Immunocore Holdings
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Revelation and Immunocore is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Immunocore Holdings go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Immunocore Holdings
Given the investment horizon of 90 days Revelation Biosciences is expected to generate 3.22 times more return on investment than Immunocore Holdings. However, Revelation Biosciences is 3.22 times more volatile than Immunocore Holdings. It trades about 0.04 of its potential returns per unit of risk. Immunocore Holdings is currently generating about 0.06 per unit of risk. If you would invest 288.00 in Revelation Biosciences on January 24, 2025 and sell it today you would lose (2.00) from holding Revelation Biosciences or give up 0.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Revelation Biosciences vs. Immunocore Holdings
Performance |
| Timeline |
| Revelation Biosciences |
| Immunocore Holdings |
Revelation Biosciences and Immunocore Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and Immunocore Holdings
The main advantage of trading using opposite Revelation Biosciences and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
| Immunocore Holdings vs. Arcellx | Immunocore Holdings vs. Ventyx Biosciences | Immunocore Holdings vs. Vaxcyte | Immunocore Holdings vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |